|
|
Volumn 34, Issue 5, 2002, Pages 1966-1967
|
|
Experience with the use of basiliximab in liver transplantation - Use in pediatric and adult recipients in combination with cyclosporine or tacrolimus
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
PREDNISONE;
STEROID;
TACROLIMUS;
BASILIXIMAB;
CYCLOSPORIN;
HYBRID PROTEIN;
MONOCLONAL ANTIBODY;
CONFERENCE PAPER;
FOLLOW UP;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
INCIDENCE;
LIVER FUNCTION TEST;
LIVER TRANSPLANTATION;
PRIORITY JOURNAL;
ADULT;
AGE;
ARTICLE;
BLOOD;
CHILD;
COMPARATIVE STUDY;
DRUG COMBINATION;
IMMUNOLOGY;
MORTALITY;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
TIME;
ADULT;
AGE FACTORS;
ANTIBODIES, MONOCLONAL;
CHILD;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
RECOMBINANT FUSION PROTEINS;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
TACROLIMUS;
TIME FACTORS;
|
|
EID: 0035993834
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03142-1 Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (8)
|
